Valeo Pharma Inc. Enters into an Agreement for Enerzair® Breezhaler® and Atectura® Breezhaler® in Canada ...Middle East

News by : (PR Newswire) -
Valeo to commercialize Enerzair® Breezhaler® and Atectura® Breezhaler®, 2 innovative asthma therapies approved by Health Canada Positions Valeo as one of the leading Canadian Respiratory companies Almost 4 million Canadians afflicted with asthma1; Canadian market for asthma medication...

Hence then, the article about valeo pharma inc enters into an agreement for enerzair breezhaler and atectura breezhaler in canada was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Valeo Pharma Inc. Enters into an Agreement for Enerzair® Breezhaler® and Atectura® Breezhaler® in Canada )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار